Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Segal

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Postgraduate Medicine|August 1, 1980
Hypertensive emergencies: practical approach to treatmentJ L Segal
Clinical Pharmacokinetics|August 1, 1989
Clinical pharmacokinetics in patients with spinal cord injuriesJ L Segal, S R Brunnemann
American Journal of Therapeutics|November 13, 2001
Optimal drug therapy and therapeutic drug monitoring after spinal cord injury: a population-specific approachJ L Segal, M S Pathak
Life Sciences|January 1, 1991
Amikacin serum protein binding in spinal cord injuryS R Brunnemann, J L Segal
The Journal of Spinal Cord Medicine|December 24, 1998
4-Aminopyridine alters gait characteristics and enhances locomotion in spinal cord injured humansJ L Segal, S R Brunnemann
Pharmacotherapy|May 1, 1997
4-Aminopyridine improves pulmonary function in quadriplegic humans with longstanding spinal cord injuryJ L Segal, S R Brunnemann
The Journal of the American Paraplegia Society|January 1, 1993
Circulating levels of soluble interleukin 2 receptors are elevated in the sera of humans with spinal cord injuryJ L Segal, S R Brunnemann
The American Journal of Gastroenterology|March 1, 1995
Gastric emptying is impaired in patients with spinal cord injuryJ L Segal, N Milne, S R Brunnemann
Southern Medical Journal|September 1, 1981
Diazepam-cimetidine drug interaction: a clinically significant effectR L Ruffalo, J F Thompson, J L Segal
Antimicrobial Agents and Chemotherapy|January 1, 1993
Comparison of population pharmacokinetic models for gentamicin in spinal cord-injured and able-bodied patientsT M Gilman, S R Brunnemann, J L Segal
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Postgraduate Medicine|August 1, 1980
Hypertensive emergencies: practical approach to treatmentJ L Segal
Clinical Pharmacokinetics|August 1, 1989
Clinical pharmacokinetics in patients with spinal cord injuriesJ L Segal, S R Brunnemann
American Journal of Therapeutics|November 13, 2001
Optimal drug therapy and therapeutic drug monitoring after spinal cord injury: a population-specific approachJ L Segal, M S Pathak
Life Sciences|January 1, 1991
Amikacin serum protein binding in spinal cord injuryS R Brunnemann, J L Segal
The Journal of Spinal Cord Medicine|December 24, 1998
4-Aminopyridine alters gait characteristics and enhances locomotion in spinal cord injured humansJ L Segal, S R Brunnemann
Pharmacotherapy|May 1, 1997
4-Aminopyridine improves pulmonary function in quadriplegic humans with longstanding spinal cord injuryJ L Segal, S R Brunnemann
The Journal of the American Paraplegia Society|January 1, 1993
Circulating levels of soluble interleukin 2 receptors are elevated in the sera of humans with spinal cord injuryJ L Segal, S R Brunnemann
The American Journal of Gastroenterology|March 1, 1995
Gastric emptying is impaired in patients with spinal cord injuryJ L Segal, N Milne, S R Brunnemann
Southern Medical Journal|September 1, 1981
Diazepam-cimetidine drug interaction: a clinically significant effectR L Ruffalo, J F Thompson, J L Segal
Antimicrobial Agents and Chemotherapy|January 1, 1993
Comparison of population pharmacokinetic models for gentamicin in spinal cord-injured and able-bodied patientsT M Gilman, S R Brunnemann, J L Segal
Pageof 4